Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Int J Urol ; 19(3): 257-63, 2012 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-22168394

RESUMO

OBJECTIVES: To determine whether angiotensin and endothelin have any role in testicular ischemia reperfusion injury by investigating the effects of the angiotensin converting enzyme inhibitor enalapril, selective non-peptide angiotensin-II type I blocker losartan and dual endothelin receptor blocker bosentan. METHODS: Rats were anesthetized with thiopental sodium (50 mg/kg i.p.) before the operation. The left testicular artery and vein of rats were occluded for 1 h; before the bilateral orchiectomy, the organ was allowed to reperfuse for 3 h or 24 h. Enalapril (20 mg/kg i.p.), losartan (30 mg/kg i.p.), bosentan (10 mg/kg i.p.) or vehicle (saline) were given 30 min before reperfusion. Malondialdehyde level was measured in testicular tissue after 3 h of reperfusion. Histological examination was carried out after 24 h of reperfusion. RESULTS: Ischemia reperfusion caused a significant increase in malondialdehyde level of ipsilateral testis, and histopathological injury in both ipsilateral and contralateral testes. Enalapril, losartan and bosentan treatments prevented the ischemia reperfusion-induced augmentation in malondialdehyde levels. Only bosentan treatment ameloriated ischemia reperfusion-induced histopathological alterations. CONCLUSIONS: Endothelin might play a more important role in pathogenesis of testicular ischemia reperfusion injury when compared with angiotensin.


Assuntos
Angiotensinas/metabolismo , Endotelinas/metabolismo , Malondialdeído/metabolismo , Traumatismo por Reperfusão/metabolismo , Testículo/irrigação sanguínea , Bloqueadores do Receptor Tipo 1 de Angiotensina II/farmacologia , Inibidores da Enzima Conversora de Angiotensina/farmacologia , Angiotensinas/efeitos dos fármacos , Animais , Bosentana , Enalapril/farmacologia , Antagonistas dos Receptores de Endotelina , Endotelinas/efeitos dos fármacos , Losartan/farmacologia , Masculino , Ratos , Ratos Wistar , Traumatismo por Reperfusão/patologia , Estatísticas não Paramétricas , Sulfonamidas/farmacologia , Testículo/metabolismo , Testículo/patologia
2.
J Pharmacol Sci ; 105(1): 94-102, 2007 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-17895592

RESUMO

Montelukast, a selective reversible cysteinyl leukotriene D(4)-receptor (LTD(4) receptor) antagonist, is used in the treatment of asthma. We have investigated alterations in the glutathione (GSH) and activity levels of antioxidative enzymes [superoxide dismutase (SOD), catalase (CAT), glutathione S-transferase (GST), and glutathione reductase (GR)] and myeloperoxidase (MPO), as markers of the ulceration process following oral administration of montelukast, lansoprazole, famotidine, and ranitidine, respectively, in rats with indomethacin-induced ulcers. In the present study, we found that 1) montelukast, lansoprazole, famotidine, and ranitidine all reduced the development of indomethacin-induced gastric damage, with this reduction occurring at a greater magnitude for montelukast, famotidine, and lansoprazole than for ranitidine; 2) montelukast and ranitidine both alleviated increases in the activity levels of CAT and GST enzymes resulting from gastric injury; 3) montelukast and ranitidine both ameliorated depressions in the GSH and activity levels of SOD and GR enzymes caused by indomethacin administration; and 4) all doses of montelukast, lansoprazole, and ranitidine decreased amplification of MPO activity resulting from induced gastric injuries. These results suggest that the gastroprotective effects of montelukast on indomethacin-induced ulcerations can be attributed to its ameliorating effect on oxidative damage and MPO activity.


Assuntos
Acetatos/farmacologia , Antioxidantes/farmacologia , Fármacos Gastrointestinais/farmacologia , Quinolinas/farmacologia , Úlcera Gástrica/prevenção & controle , 2-Piridinilmetilsulfinilbenzimidazóis/farmacologia , 2-Piridinilmetilsulfinilbenzimidazóis/uso terapêutico , Acetatos/química , Acetatos/uso terapêutico , Animais , Antiulcerosos/farmacologia , Antiulcerosos/uso terapêutico , Antioxidantes/química , Antioxidantes/uso terapêutico , Catalase/metabolismo , Ciclopropanos , Relação Dose-Resposta a Droga , Famotidina/farmacologia , Famotidina/uso terapêutico , Fármacos Gastrointestinais/química , Fármacos Gastrointestinais/uso terapêutico , Glutationa Redutase/metabolismo , Glutationa Transferase/metabolismo , Antagonistas dos Receptores H2 da Histamina/farmacologia , Antagonistas dos Receptores H2 da Histamina/uso terapêutico , Indometacina/administração & dosagem , Indometacina/toxicidade , Intubação Gastrointestinal , Lansoprazol , Masculino , Estrutura Molecular , Peroxidase/metabolismo , Quinolinas/química , Quinolinas/uso terapêutico , Ranitidina/farmacologia , Ranitidina/uso terapêutico , Ratos , Ratos Sprague-Dawley , Estômago/efeitos dos fármacos , Estômago/enzimologia , Estômago/patologia , Úlcera Gástrica/induzido quimicamente , Sulfetos , Superóxido Dismutase/metabolismo
3.
Eur J Pharmacol ; 566(1-3): 215-21, 2007 Jul 02.
Artigo em Inglês | MEDLINE | ID: mdl-17475238

RESUMO

Amiodarone is a widely used anti-arrhythmic agent. We have investigated alterations in the glutathione (GSH) level and the activities of anti-oxidative enzymes (superoxide dismutase, catalase, glutathione s-transferase and glutathione reductase) and myeloperoxidase, as marker of acute inflammation, following oral administration of amiodarone and diclofenac in rats with carrageenan-induced paw edema. In the present study, we found that 1) Amiodarone reduced the development of carrageenan-induced paw edema, to a greater degree than diclofenac; 2) Amiodarone and diclofenac alleviated increases in the activities of catalase and glutathione s-transferase enzymes resulting from edema; 3) Amiodarone and diclofenac ameliorated depressions in the GSH level and the activities of superoxide dismutase and glutathione reductase enzymes caused by carrageenan injection; and 4) All doses of amiodarone and diclofenac caused an amplification in myeloperoxidase activity resulting from induced paw edema. These results suggest that the anti-inflammatory effect of amiodarone on carrageenan-induced acute inflammation can be attributed to its ameliorating effect on the oxidative damage.


Assuntos
Amiodarona/farmacologia , Anti-Inflamatórios não Esteroides/farmacologia , Antioxidantes/farmacologia , Edema/tratamento farmacológico , Animais , Carragenina , Catalase/metabolismo , Diclofenaco/farmacologia , Edema/induzido quimicamente , Edema/metabolismo , Glutationa/metabolismo , Glutationa Redutase/metabolismo , Glutationa Transferase/metabolismo , Membro Posterior , Masculino , Peroxidase/metabolismo , Ratos , Ratos Sprague-Dawley , Superóxido Dismutase/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...